US Lawyer Database

Section 21-254 – Action Against Food That Poses Immediate Threat

    (a)    (1)    For purposes of this section, an “immediate threat” exists if any meat, seafood, poultry, vegetable, fruit, or any other perishable substance that is intended for consumption as food:             (i)    Contains any filthy, decomposed, or putrid substance;             (ii)    Is poisonous or otherwise would be injurious to health if consumed; or             (iii)    Is otherwise unsafe.         (2)    If a food poses an […]

Section 21-255 – Reporting of Criminal Violations

    (a)    Except as otherwise provided in this section, the Secretary shall report to the State’s Attorney any alleged criminal violation of this subtitle.     (b)    Before the Secretary reports any alleged violation of this subtitle to a State’s Attorney for the institution of a criminal proceeding, the Secretary shall give the alleged violator notice and an opportunity to […]

Section 21-218 – Additional Grounds of Drug Misbranding

    (a)    In this section, “antibiotic drug” means any drug that:         (1)    Is intended for use by a human being;         (2)    Contains any quantity of a chemical substance or the chemically synthesized equivalent of a chemical substance that is produced by microorganisms; and         (3)    Can inhibit or destroy microorganisms in dilute solution.     (b)    In addition to any other ground that may […]

Section 21-238 – Authorization by Permit of Exceptions to Definitions and Standards

    (a)    If a temporary permit is issued under the federal act to authorize an interstate shipment that varies from the definitions and standards of identity set under the federal act, the permit is effective in this State under the conditions provided in the permit.     (b)    For experimental or other purposes, the Secretary may issue a permit that […]

Section 21-219 – Exemptions From Labeling and Packaging Requirements for Drugs and Devices Subject to Additional Processing, Labeling, or Packing

    (a)    A drug or device is not subject to the labeling or packaging requirements of this subtitle if a rule or regulation is adopted under the federal act or as provided under this section to exempt it.     (b)    The Secretary shall adopt rules and regulations to exempt from the labeling requirements of this subtitle any drug or […]

Section 21-220 – Prescription Requirements

    (a)    A drug that is intended for use by human beings and is in any of the following classifications may be dispensed by a pharmacist only on a written prescription, an electronic prescription, as defined in § 5–101 of the Criminal Law Article, or an oral prescription from a health practitioner authorized by law to prescribe […]

Section 21-221 – Label Requirements for Prescription Drugs; Exemption From Provisions on Misbranded Drugs

    (a)    A drug that is dispensed under a prescription shall bear a label that states:         (1)    The name and address of the dispenser;         (2)    The serial number of the prescription;         (3)    The date of the prescription or the date that the prescription was filled;         (4)    The name of the prescriber; and         (5)    If stated in the prescription:             (i)    The name of the […]

Section 21-222 – Construction of 21-220 and 21-221

    Nothing in § 21-220 or § 21-221 of this subtitle relieves any person from any requirement imposed by law with respect to any drug that is classified as a controlled dangerous substance within the meaning of Title 5 of the Criminal Law Article or the applicable federal law.

Section 21-223 – New Drugs — in General

    (a)    This section does not apply to any drug that:         (1)    Was sold in this State or introduced into interstate commerce at any time before the enactment of the federal act, if its labeling contained the same representations concerning the conditions of its use; or         (2)    Is licensed under the Public Health Service Act of July 1, 1944 […]

Section 21-224 – New Drugs — Exemption When Intended for Investigational Use Only

    (a)    (1)    A new drug is not subject to the requirements of § 21-223 of this subtitle if it is exempted by a rule or regulation adopted under this section.         (2)    This section does not require any clinical investigator to submit directly to the Secretary any report on the investigational use of a drug.     (b)    The Secretary shall adopt […]